Prime Business AfricaIn the Nigerian stock market, there are five pharmaceutical companies listed, with two having majority shareholders from the south-south, one from the south-east, one from the south-west, and one from the north.
The companies are Neimeth International Pharmaceutical, Fidson Healthcare Plc, May and Baker, MeCure Industries Plc, and Morison Industries Plc.
Join our WhatsApp ChannelAs of July 27, the five companies have a combined market valuation of N206.01 billion, according to data from the Nigerian Exchange Limited (NGX).
Majority shareholder from the south-south
Fidelis Ayebae
Fidelis Ayebae is a majority shareholder in Fidson Healthcare Plc, where he serves as the managing director (MD) and chief executive officer (CEO).
Ayebae, a businessman from Edo state, holds direct shares of 758.54 million and indirect shares of 1.10 million, through Glorious Haven Limited, in Fidson Healthcare, bringing his total shareholding to 759.64 million.
According to Prime Business Africa’s analysis, Ayebae’s total shares, which represent a 33.10 percent stake in the pharmaceutical company, are valued at N33.42 billion as of June 30.
His investment increased by N21.45 billion or 179.36 percent in the first six months of this year, from N11.96 billion it was valued at the start of the year.
Charles A. Osezua
Charles A. Osezua, an Edo state indigene, is a non-executive director (NED) in Morison Industries Plc and the majority shareholder of the pharmaceutical company.
Osezua holds 185.61 million shares, representing an 18.77 percent stake, split into direct shares of 23.72 million and indirect shares of 161.89 million.
Findings showed that the value of Osezua’s total shares was N744.32 million on January 2, however, the investment value dropped to N597.68 million at the end of the second quarter, indicating a decrease of N146.63 million.
Majority shareholder from the south-east
Dukor Anderline Ndidi
While Dukor Anderline Ndidi is the second majority shareholder of Mecure Industries Plc, the businesswoman made the list due to the majority shareholder of the company being the Udani family, who are Indian investors.
The businesswoman from Anambra state holds 27.02 million shares (0.68 percent stake) in MeCure, which were valued at N375.67 million at the start of the first quarter, but dropped to N347.29 million at the end of June.
According to PBA’s analysis, this represents a decrease of N28.37 million or 7.55 percent in the investment value of Ndidi, who is also the co-chief executive officer (co-CEO) of MeCure.
Majority shareholder from the south-west
Olusegun Akanji
Olusegun Akanji is a majority shareholder of Neimeth International Pharmaceutical, where he also serves as the non-executive director (NED).
Akanji holds a direct shareholding of 251,290 or a 0.005 percent stake in Neimeth and 1.06 billion indirect shares or 25 percent stake through Clinoscope Services Limited, alongside Atinuke Uwajeh.
According to analysis, Akanji’s direct shares are valued at N1.64 million as of June 30, compared to the N630,737 they were worth on January 2, reflecting an increase of N1.01 million.
Also, the value of the indirect shares increased by N4.29 billion within the first half of the year, as it rose from N2,68 billion recorded at the start of the year, to N6,97 billion at the end of June.
Majority shareholder from the north
Theophilus Yakubu Danjuma
Theophilus Yakubu Danjuma, through his investment company, T.Y.Holdings, holds 720.87 million indirect shares in May and Baker, which makes him the majority shareholder of the pharmaceutical company.
According to PBA’s analysis, Danjuma’s shares, representing 41.78 percent, are valued at N11.17 billion as of June 30, compared to the N6.77 billion they were valued at as of January 2, indicating an increase of N4.39 billion.
For press releases, tip-offs, and corporate information, call 08149575257 (hotline), email: publisher@primebusiness.africa and editor@primebusiness.africa
